20-11-2024
It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease.
20-11-2024
The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years at the company.
20-11-2024
AI chip suppliers are enjoying a spending boom from ‘hyperscalers,’ which in turn use the technology to boost sales and profits.
20-11-2024
The chances of another rate cut this year by the Bank of England has diminished after data showed an acceleration in the pace of Britain’s inflation last month.